Culture

March/April 2021 Annals of Family Medicine Tip Sheet

Study Reveals New Hope for Men With Common Urinary Issues

A new systematic review of evidence recommends the use of behavioral self-management treatments for common urinary issues experienced by upwards of 70 percent of older men. Common symptoms include trouble urinating, increased frequency and incontinence. These symptoms can have a substantial negative impact on sleep, social functioning and quality of life. Several guidelines recommend self-management techniques like health education, advice on fluid intake, and bladder retraining; however, in practice, self-management is often excluded from the menu of treatment options that include medication and surgery.

Researchers at Bond University's Institute for Evidence-Based Healthcare found that self-management interventions reduced the severity of lower urinary tract symptoms. The reduction in symptoms appeared similar in groups receiving medications versus self-management interventions. However, compared with drugs alone, individuals who had both drug and self-management intervention experienced a small but meaningful reduction in symptom severity after six weeks. The authors recommend further research to determine the optimal components and delivery methods for self-management interventions so that these strategies can become standard options for men with lower urinary tract symptoms.

Self-Management for Men With Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis

Loai Albarqouni, MD, MSc, PhD, et al
Bond University, Queensland, Australia
https://www.annfammed.org/content/19/2/157

Treating Incontinence in Primary Care: A Doctor Versus Mobile App Trial

A mobile app designed to help women manage urinary incontinence was as effective as usual, in-person treatment of incontinence in primary care, according to new research from the Netherlands. The study included 262 women with frequent stress incontinence, overactive bladder or a mix of symptoms. Participants were randomly assigned to use a standalone mobile app called URinControl, which offered pelvic floor muscle and bladder training exercises. Those in a control group received standard care and were referred to their own primary care doctors who were broadly advised to follow the Dutch guidelines for primary care. After four months, women who used only the incontinence app and those who continued with standard care experienced similar results, with a decline in the severity of their symptoms, less frequent leakage and improved quality of life. Statistical analysis showed just over a one-half percentage point difference between the two groups' average decline in symptom severity. Therefore, the authors conclude that primary care physicians can offer care-as-usual and/or app-based treatment to women seeking help for urinary incontinence. Most importantly, the authors note, a mobile app will only be clinically relevant if it can demonstrate that it is either a less expensive option or offers an accessible and user-friendly alternative with significant long-term outcomes.

App-Based Treatment in Primary Care for Urinary Incontinence: A Pragmatic, Randomized Controlled Trial

Anne M. M. Loohuis, MD, et al
University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
https://www.annfammed.org/content/19/2/102

App-based and self-management tools have the potential to help individuals take control of their common urinary issues. In a corresponding editorial, Joel Heidelbaugh, MD, a clinical professor of family medicine and urology at the University of Michigan, discusses the significance of Loohuis et al's mobile app study and Albarqouni et al's review of self-management interventions, and highlights their value to both patients and primary care physicians. For patients, new e-health programs could help individuals manage their symptoms and improve their quality of life without medication, or they may experience additional benefits when combined with medication. For primary care physicians, apps and self-management tools might be a cost-effective and empowering strategy compared to usual care.

Self-Directed Technology to Improve Urinary Symptoms

Joel J. Heidelbaugh, MD
University of Michigan Medical School, Ann Arbor, Michigan
https://www.annfammed.org/content/19/2/100

Perspectives of US Youth During the Initial Month of the COVID-19 Pandemic

According to two national surveys by researchers at the University of Michigan Medical School, US teens and young adults are engaged in the ongoing COVID-19 pandemic with most being knowledgeable about the disease, concerned about its impacts on others, and practicing social distancing. On March 6, 2020, 70 percent reported knowledge of the pandemic, with 46 percent noting they got information from news sources. By March 20, 2020, nearly all respondents, 95 percent, reported impact. Worry about the pandemic increased from 25 to 51 percent. For some young people who weren't worried early on about the pandemic, staying at home and engaging in other preventive public health guidelines made them feel safer. Between the two surveys, pandemic preparation seemed to shift. Initially, respondents primarily reported doing nothing (36 percent), but by March 20th, 50 percent reported practicing social distancing. The authors recommend that, as public health planning evolves, it will be important to acknowledge young people's concern for others as a driver of their behavior and to create programs that are informed by their beliefs and perspectives.

Perspectives of US Youth During Initial Month of the COVID-19 Pandemic

Eric Waselewski, MD, et al
University of Michigan Medical School, Ann Arbor, Michigan
https://www.annfammed.org/content/19/2/141

Bonus: Visual Abstract

Primary Care Big Data Can Provide Opportunity for Rapid Research to Inform Patient Care, Policy During COVID-19 Pandemic

Members of the COVID-19 Primary Care Database Consortium explain how the use of big data containing millions of primary care medical records provides an opportunity for rapid research to help inform patient care and policy decisions during the COVID-19 pandemic. Established in April 2020, the Consortium brings together experts in big data, epidemiology, intensive care, primary care and statistics, as well as journal editors, patient and public representatives, and front-line clinical staff from the universities of Oxford, Cambridge, Southampton, Bristol and Nottingham

The consensus statement that the consortium has developed and described in the article aims to facilitate transparency and rigor in methodological approaches, as well as consistency in defining and reporting cases, exposures, confounders, stratification variables and outcomes in relation to the pharmacoepidemiology (i.e. the potential influence of old and new drug therapies on outcomes) of COVID-19. This is important, the authors write, because the vast majority of drugs for common conditions such as hypertension, diabetes or heart failure are prescribed in primary care practitioners in the U.K. For example, ACE-inhibitors widely prescribed by primary care doctors may impact COVID-19 outcomes. Using big data in collaborative databases may help answer questions about the interactions between medicines and COVID-19 outcomes.

The Use of Primary Care Big Data in Understanding the Pharmacoepidemiology of COVID-19: A Consensus Statement From the Covid-19 Primary Care Database Consortium

Hajira Dambha-Miller, MRCGP, PhD, et al
University of Southampton, Southampton, United Kingdom
https://www.annfammed.org/content/19/2/135

New Collaborative Care Model Offers Insight into Providing Help for Patients With Mental Health Needs

Members of the Perelman School of Medicine at the University of Pennsylvania and its health system developed and implemented a new model of collaborative care called The Penn Integrated Care (PIC) program. PIC includes a resource center to support intake, triage and referral management and collaborative care services in primary care practices. PIC was created to increase access to and engagement with mental health professionals to improve mental and physical health outcomes. Primary care physicians were able to refer patients with any mental health symptom or condition to PIC. In 12 months, 6,124 unique patients were referred from eight primary care clinics to either the PIC Resource Center or were connected with a mental health professional. Most were triaged to collaborative care or specialty health care with active referral management.

Among patients enrolled in collaborative care, the mean length of treatment was 7.2 encounters over 78 days. Remission of symptoms was achieved by almost 33 percent of patients with depression and almost 40 percent of patients with anxiety. Stakeholders viewed the program favorably. Primary care physicians perceived they were providing patients with higher quality care, and patients appreciated having someone to talk to in addition to, or instead of, receiving a medication prescription. Results provide insight into a model for launching and implementing collaborative care to meet the needs of a diverse group of patients who have a full range of mental health conditions often seen in primary care.

Addressing Common Challenges in the Implementation of Collaborative Care for Mental Health: The Penn Integrated Care Program

Courtney Benjamin Wolk, PhD, et al
University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania
https://www.annfammed.org/content/19/2/148

Use of Patient Data Guides Outreach to Treat and Monitor People With Diabetes

Researchers from the HealthPartners Institute and University of Minnesota in Minneapolis conducted an observational analysis of interviews and characteristics of primary care clinics, comparing the strategies, facilitators and barriers to high performance in treating patients with diabetes. The purpose of the study was to learn what strategies and factors seem most important to leaders of primary care clinics to ensure high performance. The percentage of Minnesota diabetes patients who achieved optimal diabetes care measures increased from 12 to 45 percent between 2004 and 2017, while national measures of diabetes care outcomes did not improve significantly around the same time span.

The main difference among the strategies and factors was the degree to which top performing clinics used patient data to guide proactive and outreach methods to intensify treatment and monitor impact. The authors state that while confirmatory studies are needed, clinic leaders should consider the value of this paradigm shift in approach to care.

Strategies and Factors Associated With Top Performance in Primary Care for Diabetes: Insights From a Mixed Methods Study

Leif I. Solberg, MD, et al
HealthPartners Institute, Minneapolis, Minnesota
https://www.annfammed.org/content/19/2/110

Standardized vs. Customized Patient Care: Finding the Right Balance

Authors from the American Medical Association and the University of Wisconsin write a commentary about finding the right balance between standardization and customization of patient care processes. They write that, in most situations, patients receive better care when physicians and their teams have the ability to exercise professional judgment about workflow and task distribution, supported by best practices of systems engineering, rather than when they are expected to perform a rigid sequence of transactions mandated by well-intentioned but distant health care designers. The authors present four principles to guide decisions between standardization and customization: develop processes and policies in collaboration with end users; share decision authority with the clinicians closest to the patients; seek measures of customization; and not all variation is bad. Finding the balance between standardization and customization is important for patient care and should be considered by organizational leadership, those who determine patient treatment standards, and health care regulators, according to the authors.

Standardization vs Customization: Finding the Right Balance

Christine A. Sinsky, MD, et al
American Medical Association, Chicago, Illinois
https://www.annfammed.org/content/19/2/171

Increased Collaboration between Primary Care Doctors, Oncologists May Improve Fragmented Cancer Care

Cancer patients often experience fragmented care, particularly as they undergo cancer treatments. Although family physicians seek to provide continuous and comprehensive care, they often lose touch with their cancer patients during the treatment phase. Researchers conducted a randomized intervention that aimed to improve continuity of care and interprofessional collaboration as perceived by lung cancer patients and their family physicians.

The components of the intervention included the bidirectional exchange of patient information and care summaries between oncology teams and family physicians. Oncology teams recommended that patients see their family physicians after their cancer diagnosis. At the same time, cancer patients received priority access to their family physicians when needed.

The authors conclude that the intervention improved patient and family physician perceptions of interprofessional collaboration. Patients reported improved care continuity. In its objective to address fragmented cancer care, the study implemented pragmatic strategies to improve information exchange between family practitioners and the oncology team that could be integrated into routine practice. These findings provide valuable insight into potential strategies to bridge the gap between primary care and oncology care.

Continuity of Cancer Care and Collaboration Between Family Physicians and Oncologists: Results of a Randomized Clinical Trial

Michele Aubin, MD, PhD, et al
Laval University, Quebec City, Québec, Canada
https://www.annfammed.org/content/19/2/117

Using Health Behavior Outcomes Can Help Determine Efficacy of Patient-Centered Intervention for People With Multiple Morbidities

Intervention research focusing on patients with multiple, simultaneous chronic illnesses is a priority for health organizations such as the National Institutes of Health and Canadian Institutes of Health Research. This is important as physicians seek to better understand how one disease may influence the course of another coexisting one, and how to best care for patients who are battling multiple health issues. Researchers conducted a controlled trial in patients 18 to 80 years with three or more chronic conditions. They collected quantitative data and conducted in-depth interviews with patients, family members and health care providers, then measured the effectiveness of a four-month intervention based on changes in care delivery. For the study, health care professionals were trained to coach patients on adopting healthy lifestyle changes and managing their own health.

After four months, the intervention showed no effect on quantitative measures of self-management or self-efficacy. However, patients reported in qualitative interviews that the intervention improved their self-management and self-efficacy. The authors warn that complex interventions can be difficult to evaluate and important effects may be missed in evaluations that only include quantitative assessments.

Scaling Up Patient-Centered Interdisciplinary Care for Multimorbidity: A Pragmatic Mixed-Methods Randomized Controlled Trial

Martin Fortin, MD, MSc, et al
Universite de Sherbrooke, Sherbrooke, Québec, Canada
https://www.annfammed.org/content/19/2/126

It's Time to Expand Chlamydia Treatment for Gay and Bisexual Men

In most US states, many gay and bisexual men are excluded from one effective approach to treating the sexually transmitted infection chlamydia. Because of nearly decade-old CDC guidelines that have been adopted in most states, health care practitioners are discouraged from offering an extra dose of antibiotic treatment for chlamydia for a patient's partner, without requiring that partner to be tested or examined, a practice that is called expedited partner therapy (EPT). Although EPT remains a highly effective way to break the cycle of reinfection, the CDC recommends against offering EPT to men who have sex with men, citing the lack of clinical trial evidence in this population and the risk of undetected coinfections like HIV. The authors of this essay note that changes in the HIV prevention landscape over the past ten years should prompt policy makers and public health officials to reevaluate the risks and benefits of expedited partner therapy for gay and bisexual men and their sexual networks. PrEP, or pre-exposure prophylaxis, was introduced to US markets in 2012. The popularity of PrEP among certain gay and bisexual men, the authors argue, connects patients who might not otherwise engage in preventive care to more frequent and comprehensive infection screenings and services. Additionally, they argue that limiting EPT to heterosexual people may discourage open and accurate conversations between doctor and gay and bisexual patients and point to an urgent need for data to understand the effectiveness and downstream effects of expedited partner therapy in this population.

It's Time to Expand Chlamydia Treatment for Gay and Bisexual Men

Hannan M. Braun, MD and Jessica L. Taylor, MD
Boston Medical Center, and Boston University, Boston, Massachusetts
https://www.annfammed.org/content/19/2/168

Innovations in Primary Care

Innovations in Primary Care are brief one-page articles that describe novel innovations from health care's front lines. In this issue:

Combination of Home-Based Hormonal and Mobile Technology for Virtual Monitoring of Menstrual Cycles--Smartphone applications combined with home-based hormonal tests can be effectively used for virtual physician monitoring of patients/ menstrual cycles.

https://www.annfammed.org/content/19/2/180

The Impact of COVID-19 Proactive Outreach With Somali Seniors--The COVID-19 positivity rate for Somalis in Minneapolis is disproportionately high. A targeted health outreach program paired bilingual volunteers with high-risk patients to provide education on COVID-19 and general health support over the phone.

https://www.annfammed.org/content/19/2/179
Medical School Affiliation Accelerates the Development of Community Health Centers in China--A program to build a bridge between China's community health centers and academic institutions has resulted in a relationship that has the potential to improve how family medicine is delivered.

https://www.annfammed.org/content/19/2/178

Credit: 
American Academy of Family Physicians

Unveiling the cause of onion center rot

image: Pantaphos, which is produced by the plant pathogen Pantoea ananatis, is responsible for causing onion center rot.

Image: 
Alex Polidore

Since 1983, the bacteria Pantoea ananatis has been known to infect several important crops including onions, rice, and corn. It was unclear, however, what molecules were involved. A new study, published in mBio, has identified one of the culprits: pantaphos. Intriguingly, the researchers have discovered that pantaphos can also act as an herbicide and it is toxic to glioblastoma cells, making it an exciting candidate for agricultural and biomedical applications.

"Herbicide resistant weeds are an issue in agriculture," said William Metcalf (MMG leader), a professor of microbiology. "Unfortunately, there hasn't been a new class of herbicide for over 30 years. If we can understand how pantaphos causes onion rot, we can solve a big problem."

Scientists at Cornell University had previously compared the disease-causing strains of P. ananatis to other innocuous strains. They identified a group of genes, designated as hvr, that were responsible for causing onion rot. The researchers in the current paper were inspired by these studies, and they subsequently identified which molecules were produced by these genes and found pantaphos.

"We can inject onions with purified pantaphos and cause onion rot. The injected onions start rotting, and become gross and mushy. It was exciting to see," said Alexander Polidore, a PhD student in the Metcalf lab. "Additionally, bacteria that cannot synthesize this molecule cannot cause onion rot, which means that it is necessary to cause the infection."

"If we can fully understand how pantaphos is made by the bacteria, we can identify multiple steps of intervention. If we can stop any one of those processes, we can get rid of onion rot," Metcalf said.

Intriguingly, pantaphos has also shown promise as an effective herbicide. "I compared pentaphos to Liberty and Roundup, which are common herbicides, and it was just as good--or even better--against typical weeds such as mustard seedlings," Polidore said.

An important requirement for an herbicide is that it kills weeds, but remains non-toxic to other animals, including humans. Therefore, the researchers tested the toxicity of pantaphos against other organisms. "Although it does not affect other bacteria and fungi, we found that it is moderately toxic to normal human cell lines, but strikingly toxic to glioblastoma cell lines. We were excited because those cancer cells are notoriously hard to kill," Polidore said.

Although pantaphos is somewhat toxic to human cell lines, it is possible that it will not be toxic to whole animals. "If you feed pantaphos to a mouse and it doesn't get taken up in the intestine, it will be much less toxic," Metcalf said. "Thus, our cell line studies are preliminary and will require follow-up experiments to define the level of toxicity in humans."

The researchers are currently trying to understand how pantaphos kills weeds and glioblastoma cells. The results of those studies may help them design modified versions of the molecule that affect only the desirable targets. Using bioinformatic analysis, they have also found similar hvr genes in other bacteria, indicating that there may be several pantaphos-like molecules that could be used as potential herbicides or therapeutic drugs.

Credit: 
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign

Evidence review examines both benefits and harms for lung cancer screening

image: "Two large studies have now confirmed that screening can lower the chance of dying of lung cancer in high-risk people. However, people considering screening should know that a relatively small number of people who are screened benefit, and that screening can also lead to real harms," said Daniel Reuland, MD, MPH, one of the review authors, a member of the UNC Lineberger Comprehensive Cancer Center, and a professor in the division of General Medicine and Clinical Epidemiology at UNC School of Medicine.

Image: 
UNC Lineberger Comprehensive Cancer Center

CHAPEL HILL, NC -- A comprehensive review by University of North Carolina researchers and colleagues of hundreds of publications, incorporating more than two dozen articles on prevention screening for lung cancer with low-dose spiral computed tomography (LDCT), shows there are both benefits and harms from screening. The review is published in JAMA on March 9, 2021.

The results of the decadelong National Lung Screening Trial (NLST) showed that LDCT could detect lung cancer better than conventional X-rays in current or previous heavy smokers. Based on those results, the United States Preventive Services Task Force (USPSTF) initially recommended low-dose CT screening for people ages 55 to 80 with a 30 pack-year smoking history. Subsequently, other screening trial results have been published, including a European trial called NELSON, the next-largest study to the NLST. NELSON also found a reduction in deaths due to lung cancer because of screening.

It has been nearly a decade since the initial recommendations were formulated, so the USPSTF initiated an updated review of the evidence. UNC scientists and their collaborators evaluated and synthesized data from the seven trials to arrive at a comprehensive, current assessment of harms and benefits of screening.

New recommendations, based on this evidence review, broaden the criteria for screening eligibility by lowering the screening age from 55 to 50 and reducing the pack-year requirement from 30 to 20 pack-years. There were several reasons for this change in eligibility according to the reviewers; one was to promote health equity, in part because African Americans have higher lung cancer risk even with lower levels of smoking exposure.

"Two large studies have now confirmed that screening can lower the chance of dying of lung cancer in high-risk people. However, people considering screening should know that a relatively small number of people who are screened benefit, and that screening can also lead to real harms," said Daniel Reuland, MD, MPH, one of the review authors, a member of the UNC Lineberger Comprehensive Cancer Center, and a professor in the division of General Medicine and Clinical Epidemiology at UNC School of Medicine.

In screening with CT scans, doctors are looking for lung spots or nodules that might represent early lung cancer. Harms from screening can come from the fact that the large majority of the nodules found on screening are not cancer. These findings are known as false positives, and patients with these results usually require additional scans to see if the spots are growing over time. In some cases, these false positives lead to unnecessary surgery and procedures. Throughout the process, patients may experience the mental distress of a possible cancer diagnosis.

"Applying screening tests to a population without symptoms of disease can certainly benefit some people but also has the potential for some harms," said lead author Daniel Jonas, MD, MPH, who conducted most of this research while he was a professor at the UNC School of Medicine and now is director of the division of general internal medicine at Ohio State University. "In the case of lung cancer screening, we now have more certainty that some individuals will benefit, with some lung cancer deaths prevented, and we also know others will be harmed. The USPSTF has weighed the overall benefits and harms, and on balance, based on our review and from modeling studies, has determined that screening with LDCT has an overall net benefit for high-risk people ages 50 to 80."

Reuland and Jonas note that, encouragingly, lung cancer rates are declining, reflecting changing smoking patterns in recent decades. Therefore, the population eligible for screening is also projected to decline. At this point, however, they don't foresee these trends changing screening recommendations during the next decade or so.

"Different trials have used different screening approaches, and we still do not know how often screening should be done or which approach to categorizing lesions is best for reducing the harms, costs and burdens of screening while retaining the benefits," said Reuland, who is also a research fellow at UNC's Cecil G. Sheps Center for Health Services Research. "I would prioritize this as an important area of future research, as it could likely be addressed by implementing less expensive studies or using approaches other than those used in the large trials we just reviewed."

Credit: 
UNC Lineberger Comprehensive Cancer Center

Humidity in breath makes cotton masks more effective at slowing the spread of COVID-19

video: A swatch of cotton fabric that has been exposed to high humidity typical of a person's exhaled breath (left) filters out more droplets than a swatch of cotton fabric that has not been exposed to high humidity (right).

Image: 
NIST

Researchers have come up with a better way to test which fabrics work best for masks that are meant to slow the spread of COVID-19. By testing those fabrics under conditions that mimic the humidity of a person's breath, the researchers have obtained measurements that more accurately reflect how the fabrics perform when worn by a living, breathing person.

The new measurements show that under humid conditions, the filtration efficiency -- a measure of how well a material captures particles -- increased by an average of 33% in cotton fabrics. Synthetic fabrics performed poorly relative to cotton, and their performance did not improve with humidity. The material from medical-procedure masks also did not improve with humidity, though it performed in roughly the same range as cottons.

This study, conducted by scientists at the National Institute of Standards and Technology (NIST) and the Smithsonian's Museum Conservation Institute, was published in ACS Applied Nano Materials.

An earlier study by the same research team showed that dual-layer masks made of tightly woven cotton fabrics with a raised nap, such as flannels, are particularly effective at filtering breath. That study was conducted under relatively dry conditions in the lab, and its main finding still stands.

"Cotton fabrics are still a great choice," said NIST research scientist Christopher Zangmeister. "But this new study shows that cotton fabrics actually perform better in masks than we thought."

The researchers also tested whether humidity makes the fabrics harder to breathe through and found no change in breathability.

The Centers for Disease Control and Prevention (CDC) recommends that people wear masks to slow the spread of COVID-19. When worn correctly, those masks filter out some of the virus-filled droplets that an infected person exhales and also offer some protection to the wearer by filtering incoming air.

This study is one of several, conducted by NIST and other organizations, that contributed to the first standards for fabric masks meant to slow the spread of COVID-19. Those standards were recently released by the standards-developing organization ASTM International.

The filtration efficiency of cotton fabrics increases in humid conditions because cotton is hydrophilic, meaning it likes water. By absorbing small amounts of the water in a person's breath, cotton fibers create a moist environment inside the fabric. As microscopic particles pass through, they absorb some of this moisture and grow larger, which makes them more likely to get trapped.

[See more images of what's happening on a microscopic level inside your mask]

Most synthetic fabrics, on the other hand, are hydrophobic, meaning they dislike water. These fabrics do not absorb moisture, and their filtration efficiency does not change in humid conditions.

For this study, the team tested fabric swatches, not actual masks. First, they prepared dual-layer fabric swatches by placing them inside a small box where the air was maintained at 99% humidity -- roughly the same as a person's exhaled breath. For comparison, a second set of swatches were prepared at 55% humidity. After the fabrics reached an equilibrium with the humidified air, the researchers placed them in front of a pipe that emitted air at about the same velocity as exhaled breath. That air carried salt particles in a range of sizes typical of the droplets that a person exhales when breathing, speaking and coughing. This salt particle method is recommended by the CDC's National Institute for Occupational Safety and Health (NIOSH) for measuring the filtration performance of mask-making materials.

The researchers calculated filtration efficiency by measuring the number of particles in the air before and after it passed through the fabric. They measured breathability by measuring the air pressure on both sides of the fabric as the air passed through it.

The researchers tested nine different types of cotton flannel, which under humid conditions increased their filtration efficiencies from 12% to 45%, with an average increase of 33%. They tested six types of synthetic fabric, including nylon, polyester and rayon. All performed poorly in comparison to cotton flannel regardless of humidity. Medical-procedure masks and N95 respirator masks provided the same filtration efficiency under both high and low humidity conditions.

While the change in performance for cotton flannels is large, they don't actually absorb very much water. Under humid conditions, a two-layer cotton flannel mask absorbs about 150 milligrams of water from human breath, the equivalent of just one or two drops. If fabric masks actually get wet in other ways, they may become difficult to breathe through, and the CDC advises that people not wear them for activities such as swimming. If masks become wet due to weather, they should be changed.

While this research provides useful information for people who wear face masks, it also holds lessons for scientists who are working to improve masks and measure their performance.

"To understand how these materials perform in the real world," Zangmeister said, "we need to study them under realistic conditions."

Credit: 
National Institute of Standards and Technology (NIST)

Gigantic jet spied from black hole in early universe

image: The main panel of this graphic is an artist's illustration of a
close-up view of a quasar and its jet, like the one in PJ352-52. The inset contains X-ray data from
Chandra of PJ352-15 (purple) that has been combined with optical and infrared data from the GeminiNorth telescope and the Keck-I telescope respectively. This result may help explain how the biggest
black holes formed at a very early time in the Universe's history.

Image: 
X-ray: NASA/CXO/JPL/T. Connor; Optical: Gemini/NOIRLab/NSF/AURA; Infrared: W.M. Keck Observatory; Illustration: NASA/CXC/M.Weiss

Astronomers have discovered evidence for an extraordinarily long jet of particles coming from a supermassive black hole in the early universe, using NASA's Chandra X-ray Observatory.

If confirmed, it would be the most distant supermassive black hole with a jet detected in X-rays. Coming from a galaxy about 12.7 billion light-years from Earth, the jet may help explain how the biggest black holes formed at a very early time in the universe's history.

The source of the jet is a quasar - a rapidly growing supermassive black hole - named PSO J352.4034-15.3373 (PJ352-15 for short), which sits at the center of a young galaxy. It is one of the two most powerful quasars detected in radio waves in the first billion years after the big bang, and is about a billion times more massive than the Sun.

How were supermassive black holes able to grow so quickly to reach such an enormous mass in this early epoch of the universe? This is one of the key questions in astronomy today.
 

Despite their powerful gravity and fearsome reputation, black holes do not inevitably pull in everything that approaches close to them. Material orbiting around a black hole in a disk needs to lose speed and energy before it can fall farther inwards to cross the so-called event horizon, the point of no return. Magnetic fields can cause a braking effect on the disk as they power a jet, which is one key way for material in the disk to lose energy and, therefore, enhance the rate of growth of black holes.  

"If a playground merry-go-round is moving too fast, it's hard for a child to move towards the center, so someone or something needs to slow the ride down," said Thomas Connor of NASA's Jet Propulsion Laboratory (JPL) in Pasadena, California, who led the study. "Around supermassive black holes, we think jets can take enough energy away so material can fall inward and the black hole can grow."
 

Astronomers needed to observe PJ352-15 for a total of three days using the sharp vision of Chandra to detect evidence for the X-ray jet. X-ray emission was detected about 160,000 light-years away from the quasar along the same direction as much shorter jets previously seen in radio waves by the Very Long Baseline Array. By comparison, the entire Milky Way spans about 100,000 light-years.

PJ352-15 breaks a couple of different astronomical records. First, the longest jet previously observed from the first billion years after the big bang was only about 5,000 light-years in length, corresponding to the radio observations of PJ352-15. Second, PJ352-15 is about 300 million light-years farther away than the most distant X-ray jet recorded before it.. 

"The length of this jet is significant because it means that the supermassive black hole powering it has been growing for a considerable period of time," said co-author Eduardo Bañados of the Max Planck Institute for Astronomy (MPIA) in Heidelberg, Germany. "This result underscores how X-ray studies of distant quasars provide a critical way to study the growth of the most distant supermassive black holes."

The light detected from this jet was emitted when the universe was only 0.98 billion years old, less than a tenth of its present age. At this point, the intensity of the cosmic microwave background radiation left over from the big bang was much greater than it is today. 
 

As the electrons in the jet fly away from the black hole at close to the speed of light, they move through and collide with photons making up the cosmic microwave background radiation, boosting the energy of the photons up into the X-ray range to be detected by Chandra. In this scenario, the X-rays are significantly boosted in brightness compared to radio waves. This agrees with the observation that the large X-ray jet feature has no associated radio emission.

"Our result shows that X-ray observations can be one of the best ways to study quasars with jets in the early Universe," said co-author Daniel Stern, also of JPL. "Or to put it another way, X-ray observations in the future may be the key to unlocking the secrets of our cosmic past."
 

Credit: 
Center for Astrophysics | Harvard & Smithsonian

Problematic internet use and teen depression are closely linked, new Concordia study finds

image: István Tóth-Király: "We think that problematic internet use and depressive symptoms are likely to be co-occurring instead of one determining the other."

Image: 
Concordia University

Most teenagers don't remember life before the internet. They have grown up in a connected world, and being online has become one of their main sources of learning, entertaining and socializing.

As many previous studies have pointed out, and as many parents worry, this reality does not come risk-free. Whereas time on the internet can be informative, instructive and even pleasant, there is already significant literature on the potential harm caused by young children's problematic internet use (PIU).

However, a new study led by István Tóth-Király, a Horizon Postdoctoral Fellow at the Substantive-Methodological Synergy Research Laboratory in Concordia's Department of Psychology, is one of only a few that examines PIU's effects on older adolescents. The paper was co-written by professor of psychology Alexandre Morin and Lauri Hietajärvi and Katariina Salmela-Aro of the University of Helsinki.

The paper, published in the journal Child Development, looks at data gathered by a longitudinal study of 1,750 high school students in Helsinki over three years.

It begins by asking three big questions: what were some of the predictors or determinants of PIU? How did PIU change over the course of late adolescence, in this case, ages 16-19? And what are the consequences of PIU among the age group?

At-risk signals

The researchers identified three principal determinants of PIU among adolescents. The first was loneliness, defined as a lack of satisfying interpersonal relationships or the perceived inadequacy of social networks. Other studies on PIU also identified loneliness as a predictor.

Parenting practices, as perceived by the teen, also predicted PIU. The researchers looked at both parental caring, such as the expressions of warmth, empathy, interest and closeness towards the child, and parental neglect, defined as the uneven availability or unresponsiveness to the child's needs.

Not surprisingly, better parenting is linked to lower PIU, while neglectful parenting is linked to higher PIU. The researchers noted the differences in how maternal and paternal behaviour affected usage.

Maternal caring especially was associated with lower PIU, suggesting that high-quality mother-child relationships might have led to a decrease in the need to use the internet excessively. Paternal neglect, on the other hand, had a stronger relationship with higher PIU, as a lack of guidance and limits hindered a teen's ability to set personal boundaries.

Finally, the researchers considered gender. They found boys more likely to engage in PIU than girls, as they tend to be prone to more addictive-like behaviour, are more impulsive and, as suggested by other studies, may have more online options such as gaming or watching YouTube videos or pornography. Girls may be more likely to be online for socializing purposes.

Circular and harmful effects

The researchers then looked at outcomes associated with PIU, again identifying three broad categories.

The first is depressive symptoms. If left unchecked, PIU appears to come with higher levels of depression. The two have been linked in previous studies, but Tóth-Király says their findings suggest a new interpretation.

"Our study tries to understand this relationship in a bi-directional or reciprocal way," he says. "We think that PIU and depressive symptoms are likely to be co-occurring instead of one determining the other. They likely reinforce one another over time."

The other outcomes linked to PIU are higher levels of substance abuse and lower levels of academic achievement. These were to be expected, and were also believed to be co-occurring.

Tóth-Király says some teens go through a phase of heavy internet use, usually around mid-adolescence. Time spent online tends to decrease as the children mature, develop their own goals and boundaries and form their first romantic relationships. He adds that being online for hours is not necessarily damaging, even if it does seem excessive to parents.

"If adolescents spend a lot of time on the internet but it doesn't really impact their mental health or their grades or doesn't seem to have any substantial negative consequences, then we cannot really say this is problematic behaviour," he says.

Credit: 
Concordia University

More collaboration between primary care and oncology may improve fragmented cancer care

Cancer patients often experience fragmented care, particularly as they undergo cancer treatments. Although family physicians seek to provide continuous and comprehensive care, they often lose touch with their cancer patients during the treatment phase. Researchers conducted a randomized intervention that aimed to improve continuity of care and interprofessional collaboration as perceived by lung cancer patients and their family physicians.

The components of the intervention included the bidirectional exchange of patient information and care summaries between oncology teams and family physicians. Oncology teams recommended that patients see their family physicians after their cancer diagnosis. At the same time, cancer patients received priority access to their family physicians when needed.

The authors conclude that the intervention improved patient and family physician perceptions of interprofessional collaboration. Patients reported improved care continuity. In its objective to address fragmented cancer care, the study implemented pragmatic strategies to improve information exchange between family practitioners and the oncology team that could be integrated into routine practice. These findings provide valuable insight into potential strategies to bridge the gap between primary care and oncology care.

Credit: 
American Academy of Family Physicians

Floral probiotics reduce apple disease

image: Researchers applying probiotic sprays to blooming apple trees at the Connecticut Agricultural Experiment Station.

Image: 
Zhouqi Cui, Regan B. Huntley, Neil P. Schultes, Blaire Steven, and Quan Zeng

While many celebrate apple blossoms as classic signs of spring, they are also welcoming entry gates for pathogens. Full of nutrients to lure pollinators and promote pollen germination, flowers also attract bacteria like Erwinia amylavora, a pathogen that causes a damaging disease called fire blight. However, recent work by scientists at the Connecticut Agricultural Experiment Station suggests that these flowery infection sites might also be perfect targets for applying microbial fire blight biocontrol measures.

In a paper recently published in Phytobiomes Journal, researchers Zhouqi Cui, Regan Huntley, Neil Schultes, Blaire Steven, and Quan Zeng found that treating apple flowers with a probiotic spray reduced incidence of fire blight. They sprayed blooming trees with different strains of bacteria isolated from apple flowers and then exposed the same blooms to the fire blight pathogen. After this inoculation, they sampled the floral microbiomes and observed the development of fire blight symptoms.

They found flowers treated with Pantoea spp. bacteria developed distinct microbiomes and exhibited fire blight symptoms 35 to 45 percent less frequently than flowers treated with just water. These results suggest that Pantoea spp. structure floral microbiomes in a way that reduces infection and could be an effective probiotic biocontrol for fire blight. Flowers may be a particularly promising system in which growers can actively influence microbiomes--compared to roots and leaves, flowers are short-lived, which could make reshaping their microbiomes both more technically feasible and biologically impactful.

This research underscores the importance of studying apple flower ecology in the field. While many researchers simply screen bacterial isolates in the laboratory, Cui and colleagues studied how these natural strains altered flower microbiomes and disease rates in the field. This step was crucial as the bacterial strain that suppressed the fire blight pathogen most strongly in the lab failed to substantially reduce infections in the field while Pantoea spp., the strain with the promising fire blight reduction in the field, did not directly suppress pathogen growth in the lab.

The authors suggest that the ineffectiveness of biocontrol agents in field settings may be due to the products' incompatibility with natural plant microbiomes. "Typical studies...often fail to even test if the applied strain effectively colonizes the flower" the authors note. As evidenced in their study, laboratory results can sometimes show false promise, but in some incidences--as with the case of Pantoea, may allow promising biocontrol agents to be overlooked.

Credit: 
American Phytopathological Society

Unconscious biases can drive foodborne illness outbreaks, MU researchers find

image: Harvey James believes studying unconscious biases can help researchers learn how outbreaks are born.

Image: 
University of Missouri

COLUMBIA, Mo. - In the midst of a pandemic that has claimed more than 2 million lives worldwide and disrupted nearly every facet of society since it appeared more than a year ago, understanding the factors that create and facilitate disease outbreaks is more important than ever. Now, researchers at the University of Missouri have determined that cognitive biases -- patterns of errors in thinking that affect judgments and behaviors, often unconsciously -- can help create and worsen foodborne disease outbreaks.

"Unethical behavior isn't always intentional; conflicts of interest and other unconscious motivations can lead people to behave in ways that help outbreaks emerge and spread," said Harvey James, associate director of the division of applied social sciences and a professor of agricultural and applied economics in the MU College of Agriculture, Food and Natural Resources (CAFNR). "If we can understand what motivates a store owner to re-open too early or a food producer to cut corners, then we can create better policies and regulations that nudge people in the right direction without restricting their freedoms."

James and Michelle Segovia, an assistant professor of agricultural and applied economics in CAFNR, were eager to apply the science of behavioral ethics to the field of food safety. Behavioral ethics examines why people make ethical and unethical decisions; to see how those choices might contribute to a foodborne disease outbreak, the researchers turned to the case of Jensen Farms.

In 2011, the Colorado cantaloupe producer was found to be responsible for an outbreak of Listeria at its packing plant that led to one of the worst foodborne illness outbreaks in U.S. history, resulting in 33 deaths across 28 states. The outbreak occurred despite Jensen Farms having recently audited their food safety procedures and installed new cleaning equipment.

To explain this contradiction, the researchers identified several forms of cognitive bias at work. Motivated blindness, for instance, encourages a person or company to advance their own interests without accounting for conflicts of interest. In the case of Jensen Farms, James and Segovia theorized that motivated blindness was to blame for the choice to hire a lenient auditor that deemed the company's food safety procedures "superior."

In addition, the researchers emphasized the unconscious nature of cognitive biases with an example of omission bias, in which the lack of action, rather than a specific harmful action, can create unfortunate consequences. Though Jensen Farms possessed equipment capable of cleaning cantaloupes with an antibacterial wash, the antibacterial function was not used prior to the outbreak.

"Jensen Farms believed they were making their cantaloupes safer even as they failed to take actions that could have prevented an outbreak," James said. "This is a perfect example of the fact that unethical behavior does not need to be a conscious act. There isn't always an easy 'villain,' so if laws and policies only address people who are intentionally propagating an outbreak, we are missing a big part of the picture. This study is a step toward recognizing the immense consequences of inadvertent and unintentional behavior."

While COVID-19 is not considered a foodborne illness, James believes that the lessons learned about cognitive biases from the study are relevant to the current pandemic. Motivated blindness, for example, could explain why some restaurants and other businesses have refused to abide by lockdown orders for fear of losing business. Herding behavior -- a bias that occurs when people follow the crowd even if they disagree with the crowd's behavior -- explains the surge in demand for certain essential items and subsequent nationwide shortages.

Credit: 
University of Missouri-Columbia

More evidence is urgently needed on opioid use in Black communities

March 9, 2021 - Although the prevalence of opioid use among Black people is comparatively low, the rate of opioid deaths has increased the sharpest and fastest among that population in recent years, according to an article in the March/April issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.

The review by Ayana Jordan, MD, PhD, of Yale University School of Medicine and colleagues stresses how important it is to develop much better evidence on how the opioid crisis has affected Black communities. "Focusing on the unique needs of Black people who use opioids is warranted to increase treatment initiation and adherence among a population less likely to engage with the traditional health care system," according to the authors.

Key themes in understanding and responding to the opioid crisis in Black communities

As the opioid epidemic has unfolded, most studies have focused on white populations, with limited inclusion of Black individuals. "Over the past decade, opioid overdose rates among Black people have been rising, resulting in an increasing need to obtain timely information," Dr. Jordan and coauthors write.

Dr. Jordan and coauthors performed a comprehensive review of the research literature to identify evidence relevant to opioid use among Black people. The researchers analyzed 42 studies providing up-to-date information on key themes, including:

Opioid use rates. National studies have reported relatively low rates of opioid use, especially prescription opoids, by Black individuals, compared to white individuals. However, those studies have often excluded or under-represented people with low incomes, those experiencing homelessness or unstable housing, and those who are incarcerated. All of these populations include disproportionately high numbers of Black people, due to the effects of structural racism.

"Thus, the prevalence of opioid use among Black people may be underestimated," Dr. Jordan and coauthors write. "It is also likely that the absence of culturally informed interview techniques could lead to underreporting of prescription opioid misuse in the Black community."

Overdose risk. Even though Black people are less likely to use opioids, those who start using are at higher risk of dying from an overdose than those from other races. Evidence also suggests that deaths due to synthetic opioids - particularly fentanyl - are rising rapidly among Black people.

Treatment for opioid use disorder. Research finds that Black people are less likely than white people to have access to opioid and other substance treatment options in their geographic communities and care networks. In one study, 15.5 percent of Black patients diagnosed with opioid use disorder (OUD) received treatment, compared to 21 percent of white patients. Evidence suggests that even after they receive care, Black patients have lower treatment completion rates, likely due to social determinants such as unemployment, access to transportation, and absence of culturally informed care.

Prescription opioid use. Black patients are less likely than their white counterparts to receive prescription opioid medication for pain. For Black patients who do receive opioids for treatment of non-cancer pain, there are persistent disparities in ongoing pain management, including lower daily doses and fewer days' supply of opioids, compared to white patients.

Social determinants of health. A handful of studies are beginning to document that social determinants of health - a wide range of conditions affecting many different behavioral or health outcomes - are the key drivers of opioid use and overdose risks among Black people. The authors note that more investigation needs to be undertaken to determine how social determinants of health, such as access to education, job training, food, transportation, and technology, can be harnessed to facilitate better access to opioid treatment for Black patients. The authors note that a better understanding of the social determinants of health affecting OUD among Black people is crucial for the development of "culturally acceptable treatment settings, where Black people are more likely to access care."

Dr. Jordan and colleagues see "great opportunity" for new research to understand and respond to the impact of the opioid crisis in Black communities. Priorities must include increased funding specifically earmarked by governmental agencies for research that addresses racial disparities in OUD. Dr. Jordan and colleagues conclude, "Building on the information presented here will promote better care of this population, with the hope of improving health outcomes."

Credit: 
Wolters Kluwer Health

Study: Political, economic, social factors affect local decisions about death penalty

Broad political, economic, and social factors influence disciplinary punishment. In particular, over the last half century, such considerations have shaped jurisdictions' use of the death penalty, which has declined considerably since the 1990s. A new study examined the factors associated with use of the death penalty at the county level to provide a fuller picture of what issues influence court outcomes. The study concludes that partisan politics, religious fundamentalism, and economic threat influenced local decisions about the death penalty. The study also found that the size of the African American population, which prior state-level studies have found to be associated with use of the death penalty, was not directly associated with the recent decline in the use of this punishment.

The study, by researchers at Missouri State University and American University, will appear in Criminology, a publication of the American Society of Criminology.

"It is essential to examine the local political environment and the composition of jurisdictional populations to capture the processes that influence local trial court outcomes," suggests Ethan Amidon, associate professor of criminology and criminal justice at Missouri State University, who led the study. "Although we found support for a number of perspectives that have been identified in prior state-level studies, our findings indicate that these relationships are more complex when considered at the local, decision-making level."

In the last 30 years, national reliance on the death penalty has declined across all states--from a late 20th century peak of 330 death sentences in 1994 to 32 death sentences in 2016. Most counties have also used the death penalty less.

In this study, researchers examined a variety of issues associated with the use of death sentences across three decennial periods from 1990 to 2010. They studied information from 2,572 counties or county equivalents, using information from the U.S. Census Bureau's decennial reports and its American Community Survey; they also considered information from a database that contains death sentences by county from 1991 to 2017. Prior research has studied this information primarily from a state perspective.

Among the factors examined were the percentages of people in each county who voted for the Republican presidential candidate, were religious fundamentalists (based on church membership data), were of different races and ethnicities, and were unemployed. The study measured each county's tradition of vigilantism by tallying the lynching rate in each jurisdiction.

To control for factors that could influence the use of the death penalty, the study considered several variables, including each county's number of homicides, rate of violent crime (homicides, robberies, rapes, and aggravated assaults), and rate of property crime (burglaries, larcenies, and car thefts). The study also considered total population and income inequality, as well as rates of divorce and poverty in each county.

The researchers concluded that several factors are associated with county-level reliance on the death penalty:

The degree of public support for Republican presidential candidates was directly associated with greater reliance on the death penalty over the study period. Given that the death penalty has declined over the last three decades, this means that the decrease in the use of this punishment was more gradual in jurisdictions with a growth in support for Republican presidential candidates, who tend to espouse law and order positions.

Counties with larger Protestant fundamentalist populations imposed death sentences to a greater degree, on average, than counties with smaller such populations. This contributes to a degree of persistence in the death penalty in jurisdictions where citizens remain strongly committed to fundamentalist ideologies.

The size of economically marginalized populations within counties was directly related to greater reliance on the death penalty. This relationship inverted once the size of the unemployed population reached a tipping point.

Neither the size of a county's African American and Hispanic populations nor its history of vigilantism was directly related to its jurisdictional use of the death penalty. However, the size of the African American population was associated indirectly with reliance on the death penalty in terms of its influence on jurisdictional unemployment.

The authors note their study is missing data on factors such as the percentage of religious fundamentalists and crime rate variables, and a few of the measurement procedures used by some of their sources changed across the study period, including those that provided crime data.

"Even as reliance on capital punishment has waned in the early 21st century, the nature and severity of penal punishments have continued to be shaped by the broader social, political, and economic landscapes in which they are immersed," according to John Eassey, a researcher in residence in the Justices Programs Office at American University, who coauthored the study.

Credit: 
Crime and Justice Research Alliance

Chemical signal in plants reduces growth processes in favor of defense

image: Feeding by herbivores not only causes plants to produce defense compounds, but also leads to a slowdown in growth processes. Cleavage of beta-carotene (a photosynthetic pigment) via reactive forms of oxygen (ROS = reactive oxygen species), forms beta-cyclocitral (βCC), which directly inhibits the rate-controlling enzyme of the MEP pathway.

Image: 
Kimberly Falk, Moves Like Nature

In a new study in PNAS, an international team of researchers including scientists from the Max Planck Institute for Chemical Ecology has shown that Arabidopsis thaliana plants produce beta-cyclocitral when attacked by herbivores and that this volatile signal inhibits the methylerythritol 4-phosphate (MEP) pathway. The MEP pathway is instrumental in plant growth processes, such as the production of pigments for photosynthesis. In addition to down-regulating the MEP pathway, beta-cyclocitral also increases plant defenses against herbivores. Since the MEP pathway is only found in plants and microorganisms, but not animals, knowledge of a signal molecule like beta-cyclocitral opens up new possibilities for the development of herbicides or antimicrobial agents that block this pathway (Proceedings of the National Academy of Sciences of the United States of America, March 2021, doi:10.1073/pnas.2008747118).

Trade-offs between defense and growth processes in plants

Researchers have long known that plants have limited resources that they can invest in defense against enemies or in growth and reproduction, depending on their environmental conditions. Many studies have already shown that plants increase their defenses when attacked by insects producing, for example, toxins or inhibitors of digestive enzymes that harm their attackers. However, much less is known about how herbivore attack affects growth processes in the plant. "We wanted to investigate how herbivory might affect photosynthesis and the methylerythritol 4-phosphate (MEP) pathway, a pathway making metabolites for growth that is directly supplied from photosynthesis," says first author Sirsha Mitra, who had started working on this project at the Max Planck Institute and is now an assistant professor at Savitribai Phule Pune University in Pune, India.

The MEP pathway has been a research topic at the Max Planck Institute for Chemical Ecology in Jena for several years "The MEP pathway makes the building blocks for plant isoprenoids or terpenoids, a very large family of plant metabolites involved in growth, defense and signaling," says Jonathan Gershenzon, the head of the Department of Biochemistry and one of the authors.

Beta-cyclocitral activates defense and inhibits growth

The international research team, which also included partners from the Universitat Ramon Llull in Barcelona, Spain, the Technical University in Lyngby, Denmark, and the University of Toronto, Canada, demonstrated that plants of the thale cress Arabidopsis thaliana which were fed to caterpillars of the African cotton leafworm, a generalist feeder that attacks many different plant species, increased defenses while simultaneously reducing growth processes. Using a variety of techniques from molecular biology and analytical chemistry, as well as caterpillar bioassays, the scientists were able to show that a specific volatile compound, beta-cyclocitral, formed by cleavage of beta-carotene due to a reactive form of oxygen, was responsible for this shift of resources. While beta-cyclocitral acts as a chemical signal to increase defenses, it simultaneously decreases the formation of compounds in the MEP pathway by directly inhibiting the rate-controlling enzyme of this pathway. "Of particular importance to our study was the exposure of plants to isotopically labeled carbon dioxide (13CO2) instead of the dominant atmospheric carbon dioxide (12CO2). Carbon dioxide is easily introduced into the MEP pathway via photosynthesis. This allowed us to track how the metabolic flux in the MEP pathway changed when plants switched to a defensive mode after herbivore attack and beta-cyclocitral slowed down the MEP pathway," says Louwrance Wright, one of the lead authors who is now working in South Africa. Caterpillars feeding on plants treated with beta-cyclocitral exhibited decreased growth in comparison to caterpillars feeding on untreated plants. This is further evidence of the importance of this volatile signal for plant defense.

Potential benefits in agriculture and medicine

When plants are attacked, they may have to stop growth processes in order to release sufficient resources for their defense. Beta-cyclocitral signaling is a mechanism that precisely controls this shift in resources. Beta-cyclocitral, or a more stable derivative, could therefore be applied to crops to stimulate defenses during a pest outbreak. "Since the MEP pathway is found in all plants and many microorganisms, but not in animals, it is of particular interest for the development of herbicides, as well as drugs with antimicrobial activity," says Jonathan Gershenzon, explaining the potential applications of this research. Further studies in India will now investigate whether beta-cyclocitral can increase insect resistance in crops, such as tomatoes, and whether it interacts with other already known defense signals.

Credit: 
Max Planck Institute for Chemical Ecology

Molecule with potential to treat multiple sclerosis passes toxicology testing in zebrafish

image: In addition to proving the peptide's safety when used as an anti-inflammatory agent, the results reinforce the importance of D. rerio as an alternative animal model for drug development that saves time and money.

Image: 
Instituto Butantan

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.

The venomous toadfish Thalassophryne nattereri contains a peptide (TnP) with anti-inflammatory and anti-allergic potential. Confirmation of this potential has now come via the zebrafish Danio rerio, a popular aquarium species native to South Asia that shares 70% of its genome with humans and is widely used as a model for in vivo trials in drug development.

The researchers tested TnP in D. rerio to measure its toxicity. In a little over a year, their research showed that the peptide is safe. It did not cause cardiac dysfunction or neurological problems in the toxicity tests they performed.

The study was conducted at Butantan Institute's Special Laboratory for Applied Toxinology in São Paulo (Brazil) by researchers affiliated with the Center for Research on Toxins, Immune Response and Cell Signaling (CeTICS), one of the Research, Innovation and Dissemination Centers (RIDCs) funded by São Paulo Research Foundation - FAPESP.

In addition to proving the peptide's safety when used as an anti-inflammatory agent, the results reinforce the importance of D. rerio as an alternative animal model for drug development that saves time and money.

Preclinical trials are important to prove the efficacy (therapeutic activity) of molecules in vivo and to evaluate adverse effects and safety. In drug discovery, 98% of the compounds tested in animals are abandoned before clinical tests.

In an article published in Toxicology Reports, the researchers say peptides represent about 2% of the world drug market but even so account for a market share worth about USD 20 billion.

"The results highlight a wide therapeutic index for TnP with non-lethal and safe doses from 1?nm [nanometer] to 10?μm [micrometer], without causing neurotoxicity or cardiotoxic effect. The low frequency of abnormalities [caused] by TnP was associated with the high safety of the molecule and the developing embryo's ability to process and eliminate it. TnP crossed the blood-brain barrier without disturbing the normal architecture of forebrain, midbrain, and hindbrain [the three main developmental divisions of the brain]," the authors write.

The study resulted from the master's research of João Batista-Filho, supervised by Mônica Lopes Ferreira and Carla Lima da Silva. It used the Zebrafish Platform, launched in 2015 by CeTICS (read more at: agencia.fapesp.br/22156/).

The Zebrafish Platform is available to scientists for research, offers courses on zebrafish management and biology, and does scientific dissemination. More than 160 researchers at 100 private and public institutions currently collaborate via Zebrafish Network, also created by CeTiCS.

"Science dies out without investment and FAPESP's commitment to this platform is now bearing fruit," Ferreira told. "Cutting-edge research is being done here, alongside preclinical trials that are important both to academia and industry."

Zebrafish have been used for decades in trials held in other countries, she said, adding that Brazil is closing the gap and that the animal's rapid life cycle accelerates the research process.

The freshwater species is easy to manage, reproducing fast, developing from egg to larva in 48-72 hours, and reaching adulthood at only three months of age. Zebrafish embryos are transparent and the effect of a compound on the animal's organs can easily be observed, for example.

History

Ferreira and collaborators discovered TnP (T. nattereri peptide) in 2007. Meanwhile, Lima had standardized laboratory tests to evaluate multiple sclerosis in rodents. The two researchers decided to work together to test TnP's efficacy in treatment of the disease, concluding for its anti-inflammatory and immunomodulatory functions.

The TnP family encompasses synthetic peptides containing a sequence of 13 L-amino acids in their primary structure. Synthetic products derived from TnP have been patented in at least nine countries including the US, India and Japan, as well as the EU. In Brazil, a patent application has been filed in partnership with the pharmaceutical company Cristália.

Studies conducted by the group with mice between 2013 and 2015 had already demonstrated that TnP can treat multiple sclerosis, delaying the onset of severe symptoms and improving clinical signs of the disease.

Multiple sclerosis is a chronic autoimmune inflammatory disorder of the central nervous system, in which the immune system attacks the myelin sheath that protects nerve fibers in the brain, spinal cord and optic nerves, disrupting communication with the rest of the organism. It can cause muscle weakness, vision loss, pain, and impaired motor coordination. It affects some 2.5 million people worldwide, including about 35,000 in Brazil, according to the Brazilian Multiple Sclerosis Association (ABEM).

Safety

In the article published in Toxicology Reports, the researchers say drug-induced cardiotoxicity is the main reason for drug withdrawal from the market. "For instance, between 1994 and 2006, 45% of discontinued medications had adverse effects such as cardiac ischemia and arhythmogenesis. In this line zebrafish has emerged as a model organism for cardiovascular research, investigating gene function and modeling a variety of human disease side-effects of chemotherapeutic drugs or particularly to screen drug candidates," they note.

For Batista-Filho, the study provides more evidence for the value of the zebrafish model in preclinical research. "It doesn't substitute mice, but avoids future expense on molecules that may not be promising or prove too toxic in previous phases," he said when asked about reservations regarding the use of zebrafish in trials compared with rodents.

Advocating investment in science and research in Brazil, Batista-Filho said he was overjoyed to achieve publication of his master's dissertation in a scientific journal. "I'm delighted," he said. "Publication is a milestone for any scientist. You focus on the good that research can do, but publication is recognition for the team's hard work."

Credit: 
Fundação de Amparo à Pesquisa do Estado de São Paulo

Strategies for better managing health care systems during pandemics, natural disasters

Health care systems could save lives and minimize losses by optimizing resource allocation and implementing mitigation strategies, according to two new studies. Colorado State University researchers explored how our health care systems might perform under multiple disasters and multiple waves of COVID-19, and how we can keep them functioning when we need them most.

In the first study, published in Nature Communications, Civil and Environmental Engineering Ph.D. student Emad Hassan and Associate Professor Hussam Mahmoud investigated the compound effects of pandemics and natural disasters on health care systems. They combined wildfire data with projections of the spread of COVID-19 to evaluate different strategies for managing patient demand in the event of concurrent disasters. They found that better resource allocation and mitigation strategies, such as organized evacuation, protecting shelter residents and using non-acute hospital beds, could result in fewer COVID cases and deaths.

"We showed that applying these measures can substantially reduce disease spread and improve patient outcomes," Hassan said.

A one-two punch

Wildfires occur every year in the U.S., and they increase the demands on our health care systems. Wildfire smoke victims may require some of the same resources needed by COVID patients, such as ventilators. For these reasons, Hassan and Mahmoud chose to study wildfire in conjunction with the pandemic.

To measure hospital functionality under the simultaneous burdens of pandemic and wildfire, Hassan and Mahmoud used a health care system model they developed previously and a new disease transmission model they created to predict the number of people in different stages of COVID-19. They modified a well-known disease transmission model, SEIR, to include additional stages of the disease.

SEIR stands for Susceptible, Exposed, Infectious and Recovered. The CSU researchers augmented the model to include susceptible, insusceptible, exposed, infective, quarantined, hospitalized, ICU admitted, ventilator-dependent, recovered and deceased.

Bracing for more waves

Using the two models they developed, along with publicly available data on the number and type of beds available in each hospital, Hassan and Mahmoud:

-Calculated the extent of disease transmission under various scenarios in every county in the U.S.
-Determined the risk of easing restrictions and the resulting shortage of beds by type - inpatient vs. intensive care, for example.
-Identified the counties where patient demand could exceed health care system capacity and presented mitigation strategies that could reduce the number of cases requiring medical services.

Their analysis, published in PLOS One, predicts how additional waves of COVID-19 might unfold.

The study shows that stricter COVID-19 preventive measures - including mask mandates, social distancing, and shutting down schools, workplaces and indoor activities - could reduce the number of hospitalized cases by as much as 12.8%. On the other hand, lifting restrictions could cause a spike in hospitalizations 13.7 times higher than the second wave's peak - pushing hospitals in many counties beyond their capacity.

"It really is an effective way of reflecting on additional requirements for health care systems to support additional waves," Mahmoud said.

Hassan and Mahmoud hope planners, policymakers and state officials can use their research to make decisions about additional resources and when to ease restrictions. Their disease transmission model, which predicts how many patients will be in each stage of the disease, could help hospitals allocate resources accordingly.

Odds of a double disaster trending upward
Until recently, Hassan and Mahmoud's research has focused on natural disasters and community resilience. When the World Health Organization declared a global pandemic, they shifted their focus to include pandemics, realizing the loss of life from a pandemic is far greater than the death toll from individual natural disasters.

"The reality of it is pandemics happen more often than extreme events, and the losses are obviously off the charts," Mahmoud said. "We know it will happen again in 100 years, if not less."

Hassan and Mahmoud hope their work will help improve health care management in the future, which promises more frequent and more devastating natural disasters with climate change and population growth.

"We've got to figure out how we can optimize our societies to handle all these stressors, while continuing to prosper," Mahmoud said.

Credit: 
Colorado State University

Precision BrainHealth: Personalized measure, training protocols to impact global health

image: BrainHealth Index results

Image: 
Center for BrainHealth

DALLAS (March 9, 2021) - Better brain health and performance for humankind is one step closer to reality with the successful trial of the groundbreaking BrainHealth Project. A cross-disciplinary team with the Center for BrainHealth® at The University of Texas at Dallas unveiled an easy-to-use online platform that delivers a novel, science-backed approach to measuring, improving and tracking one's own brain fitness.

A key innovation of the Project centers on the BrainHealth Index™ (BHI), which is based on a multidimensional definition of brain health and its upward potential. The BHI is a composite derived from a series of best-in-class assessments that explore multiple aspects of an individual's cognitive capacity, as well as their sense of well-being, quality of social interactions and complexity of daily routines. The result is a personalized score that becomes an individual's baseline, and that in theory has no upper limit.

"What gets measured gets managed," said Sandra Bond Chapman, PhD, lead author and chief director of the Center for BrainHealth. "For the first time ever, the BrainHealth Index gives individuals a comprehensive snapshot of their own brain's health and performance levels, which allows them to make meaningful, measurable improvements that will translate into greater quality of life no matter their starting point."

Brain Health Accessible to All

The science establishing the brain's lifelong ability to change, strengthen and adapt has been clearly demonstrated over the past three decades. Since its inception in 1999, the Center for BrainHealth has been at the forefront exploring the brain's upward potential, both in fundamental cognitive neuroscience research and also in transforming discoveries into actionable protocols that are demonstrated to work.

The just-completed BrainHealth Project trial adapted these proven protocols into a methodology that combines live virtual coaching with personalized training through an app-like online platform. The limitless scalability of this approach means that people everywhere can have access to transformational science through The BrainHealth Project.

"The BrainHealth Project heralds the accessibility of brain health for all," said Sandra Bond Chapman, PhD, founder and chief director of the Center for BrainHealth and the study's lead author. "Anyone and everyone will now have the ability to discover the unique strengths and abilities of their own brain, and to begin learning brain-healthy habits that they can adopt for measurable, lifelong impact. This is how The BrainHealth Project can play a critical role in making brain health equitable for all."

The study, soon to be published in Frontiers in Public Health, featured a 12-week trial that included 180 healthy adults between the ages of 18 and 87. Participants began by taking a set of assessments regarding their levels of cognition, well-being, daily-life complexity and social interaction. Researchers applied a proprietary algorithm to create a composite score for each individual - their personal BrainHealth Index. Participants then had one-on-one live coaching sessions with a trained clinician to understand their BHI and to set personal goals. Over the following weeks, they engaged in self-paced online training punctuated by two additional coaching sessions to review progress and fine-tune goals. The trial culminated with a second BHI.

"Learning about my brain health and how to keep strengthening it has been an enriching and positive experience in every respect," said a 69-year-old female participant. "The strategies were more personally meaningful and applicable to my daily life than I had even imagined, and there is no doubt my brain health has improved as a result of using them throughout my day."

Promising Results

Individual participant changes in the BHI ranged from a 38% decrease to a 60% improvement. Almost 80% of participants showed positive change in their BHI, and half of the participants showed at least a 10% increase, with no difference among men and women. Furthermore, the ability to create and sustain change did not depend on age - countering a commonly held misperception that the brain loses its ability to get stronger and work better as we get older (see Figure 1).

The contribution to these gains came from all domains of brain health: cognition, well-being, interaction and daily life. Some individuals improved due to increased resilience and decreased anxiety, whereas others improved due to increased innovation and social engagement.

Further analysis led to the discovery that various elements of brain health cluster in distinct ways, cutting across the domains of brain health. The researchers identified three sets of data points that tend to correlate most closely:

Resilience - measured through a person's level of meaningful activities, happiness and social support available to them

Fortitude - emotional stability derived from a sense of being anchored to something bigger than oneself, and influenced by levels of happiness, stress and anxiety

Clarity - one's ability to see a way forward by employing logical reasoning, possibility thinking, solitude to solve problems, and an ability to synthesize information rather than getting bogged down in the details

These findings reinforce the emerging understanding of brain health as a dynamic, synergistic whole. "Being able to understand brain health through the lens of these three factors was incredibly empowering for participants," said BrainHealth clinician Stacy Vernon, MS, LPC, NCC. "It helped them identify specific areas in their lives that contributed to their ability to thrive during the worst of times and to make adjustments in real time to keep gaining momentum."

The research team was encouraged to confirm that more than 90% of participants in the trial signed up to continue with the Project over the long term. "The true power of the BrainHealth Index emerges over time, as people track and sustain change in their own performance. When they begin to see the tremendous agency they have over their own brain health - their capacity for innovation, problem solving, decision making and so much more, it is truly transformative," said Dr. Chapman.

Getting Personal

The study found that the more people engaged in training and practicing new brain-healthy habits, the more their BHI tended to improve over the three-month trial. Gains were greatest for those who completed interventional training, and they leveled off when additional content provided was purely informational (see Figure 2). Participants who completed none of the training had an average 0% improvement on the BHI; those who completed all the interventional modules (cognitive training stress) had an average 15% improvement on the BHI. Beyond those modules - informational content only - there was no additional improvement on the BHI.

Individual results were driven by each participant's unique combination of factors making up their BHI, as well as the personal goals they established during one-on-one coaching sessions. Feedback from participants further underscored how powerful personalization can be. Periodic one-on-one coaching sessions emerged as one of the most compelling aspects of the trial, setting it apart from typical "brain training" apps and online games.

There was nothing automated about this experience. The composite making up each participant's BrainHealth Index was completely unique to them, and the regular coaching sessions allowed participants to set specific goals for themselves and track their progress with support and guidance from a trained clinician.

This innovative approach also taught participants to focus on their own strengths and performance, empowering each person to continue becoming the best version of themselves - another person's score and even population "averages" are not relevant or actionable.

"Until recently, I never considered that having a brain health coach could improve mental performance just as my yoga instructor and golf coach help me improve in those areas," said a 74-year-old male participant. "I am learning that brain performance can be measured and improved. I wish I had access to many of these tools while I was still working and building my career; however, I feel like my brain health and overall well-being are moving in the right direction, and that feels good at any age."

A Silver Lining from the Pandemic

As the study was conducted during the height of COVID-19, researchers were able to investigate effects of the pandemic on participants' brain health. The vast majority of participants felt heightened stress, worry and anxiety related to their health and economic well-being, and that of their loved ones.

Gaining new insights into the brain's immense ability to adapt and innovate provided the context and practical steps many needed to overcome new challenges. One 43-year-old female participant experienced the extra isolation of moving to a new city during 2020, in addition to working in an industry severely impacted by the pandemic. Once she began to see innovative solutions to some of her most significant challenges at work, she reported her stress level decreased and her sleep improved. She reported, "I finally started to feel like myself again."

Addressing a Global Crisis

The pandemic has wreaked havoc on the health and stability of individuals and economies alike over the past year, exposing multiple crises - job loss coupled with deep and permanent shifts across all industries, high rates of depression and suicidality that show no signs of letting up, and sclerotic education systems struggling to prepare the next generation to tackle the new challenges that lie ahead.

Within these crises also lies an urgent obligation to create a new and better path for the future. People everywhere will need to draw on their resilience, fortitude and clarity to solve the unpredictable future and challenges ahead and pave new avenues to thrive.

A healthy brain, optimized to function at its best, makes every aspect of life better. Armed with a new understanding of the brain's lifelong upward potential and our ability to affect it, better brain health and performance at the population level can lead to transformational worldwide change.

The workplace presents one clear example. Organizations that invest in employees' brain health and performance as a critical, measurable asset as well as a competitive advantage will position themselves to reap the rewards of a more purpose-driven, engaged and innovative workforce. At a large scale, better brain health in the workplace can spur economic transformation.

The Center for BrainHealth is part of an international collaboration that recently developed a science-based plan for economic recovery called the Brain Capital Grand Strategy. One key will be the BrainHealth Index, which has now been tested and proven through the just-completed study and could serve as a predictor of when a community, corporation or country has the wherewithal to be resilient.

"The pandemic exposed several economic challenges including the need for many workers to reset and reskill, and the need for companies to maximize their most important asset, the brain trust of their employees," said Tom Leppert, co-leader of The BrainHealth Project. "Better brain health and brain productivity can lead to significant increases in workforce output around the world, unlocking and unleashing untapped reservoirs of economic growth potential."

Public Health - Left of Boom

The potential for improved public health is just as vast. An array of population health challenges today - chronic stress, depression, anxiety, isolation, suicidality, Alzheimer's and more - are centered on the brain. An early, proactive focus on brain health can enable people to build reserve and resilience that might mitigate or even prevent decline stemming from disease, disorder or injury.

"Most people don't even think about their brains until something happens to it - boom!" said Geoff Ling, MD, PhD, a professor and physician with Johns Hopkins and a co-leader of The BrainHealth Project. "By strengthening the brain's health and function before anything ever happens to it - getting 'left of boom' - we are giving ourselves a tremendous level of protection to mitigate, overcome or even avoid some of the tough challenges that may lie ahead."

Furthermore, the demonstrated effectiveness of the online and virtual delivery for all aspects of the Project underscores the scalable opportunity for this telehealth model.

Birth of a Movement

Having successfully tested the online delivery mechanisms for the BrainHealth Index and the self-paced training modules through this trial, The BrainHealth Project will continue to scale up exponentially over the next several years, with the potential to reach millions of people worldwide, of all ages (8-100) and circumstances.

"For millions of people, their minds are a mystery to them - like computer software without a toolbar to control how it operates. The BrainHealth Project offers that toolbar to help everyone build brain health and all its emotional, social and cognitive aspects," said Ian Robertson, PhD, co-director of the Global Brain Health Institute, professor emeritus at Trinity College-Dublin, and co-leader of The BrainHealth Project.

"There is simply nothing more important than brain performance. A brain that can think critically, function under stress, be resilient in the face of trauma - a brain that is thoughtful, creative, socially active. We all need and want that kind of brain," said Admiral William McRaven (ret.), spokesperson for The BrainHealth Project. "This is an opportunity to fundamentally change the world."

Precision Health Fueled by Big Data

As tested in this trial, The BrainHealth Project will generate unprecedented amounts of data over time related to the BrainHealth Index, training utilization, mastery of new brain-healthy habits and more. This vast, anonymized data will be shared openly with collaborating researchers to uncover new insights and pave the way for precision health on a level never before seen.

"Robust data analysis and ongoing machine learning algorithms will one day allow us to move from precision health to predictive health with individualized modeling," said Dr. Chapman. "Scaling these individualized evidence-based brain health protocols will ultimately move global public health to an entirely new level."

"A generation ago, the aerobics revolution created a new awareness of our power to make our hearts healthier through exercise, which eventually led the medical establishment to embrace proactive, preventive protocols," said Mark D'Esposito, MD, neurologist and cognitive neuroscience professor at UC Berkeley. "Today, science has brought us to the cusp of a brain health revolution, and we can now envision a time when getting a check-up from the neck up will be part of every routine physical."

A New Funding Model

A revolution of such magnitude cannot be driven by scientists alone. It takes a united effort from people with influence in every level of society. The trial received visionary support from multiple philanthropic donors: Jean Ann Brock, Jennifer and Peter Roberts, Teresa and David Disiere, Estate of Alice Janet DeSanders, Kozmetsky Family Foundation, Peggy Dear, The Baldridge Foundation, The Joshua M. and Inette S. Brown Family Foundation, Folsom Charitable Foundation, Ellen and John McStay, Marlane Miller, John R. McCune Charitable Trust, The J. Willard and Alice S. Marriott Foundation, and J. Willard Marriott, Jr. Foundation.

"There is much work still to be done, and forward-thinking individuals and organizations will be critical partners in this endeavor," added Kevin Armshaw, director of development at the Center for BrainHealth. "As we scale up this initiative, we need support to reach and engage vulnerable communities, enact brain-centric policy, and enlist the medical community as ambassadors encouraging proactive, protective and preventive action."

Dr. Chapman said, "We are moving beyond the lab to equip all people with strategies and practices to manage their own brain health and performance. The BrainHealth Project will reach everyone around the globe who wants to better their brain's health, especially communities that are too often unseen and underserved. The science is clear, the mechanism is in place, and brain health equity for all is finally an achievable goal."

Credit: 
Center for BrainHealth